Skip to main content
    M

    MAIA Biotechnology Inc. (MAIA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.00
    +0.00 (+0.00%)

    Market Cap: $61.75M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    MAIA Biotechnology Inc. (MAIA) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    MAIA Biotechnology (MAIA) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, MAIA Biotechnology reported EPS of -$0.12, above the -$0.13 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    65%(11/17)
    Avg Surprise
    +6.98%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.14
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.15
    Range-$0.15 - -$0.15
    1 analysts
    EPS Revisions
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.14-7.1%
    60d ago-$0.14-7.1%
    30d ago-$0.14-7.1%
    7d ago-$0.14-7.1%
    Current-$0.15
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    MAIA has an expected report date of Mar 22, 2027.

    Earnings History

    Of the 17 quarters below that had an estimate, MAIA beat 11, missed 5 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2024, when EPS landed 76.60% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.12-$0.13-$0.13 - -$0.13+7.69%BeatN/A10 up, 1 downNov 9, 2026
    Jun 30, 2026-$0.13-$0.11-$0.11 - -$0.11-18.18%MissN/A11 up, 0 downAug 10, 2026
    Mar 31, 2026-$0.14-$0.18-$0.18 - -$0.18+22.22%BeatN/A10 up, 0 downMay 11, 2026
    Dec 31, 2025-$0.14-$0.13-$0.13 - -$0.13-5.23%MissN/A11 up, 0 downMar 23, 2026
    Sep 30, 2025-$0.27-$0.19-$0.19 - -$0.19-42.11%MissN/A11 up, 0 downNov 7, 2025
    Jun 30, 2025-$0.18-$0.25-$0.25 - -$0.25+28.00%BeatN/A11 up, 0 downAug 11, 2025
    Mar 31, 2025-$0.16-$0.18-$0.18 - -$0.18+11.11%BeatN/A11 up, 0 downMay 9, 2025
    Dec 31, 2024-$0.32-$0.35-$0.50 - -$0.20+8.57%BeatN/A20 up, 0 downMar 21, 2025
    Sep 30, 2024-$0.11-$0.47N/A+76.60%BeatN/AN/A0 up, 0 downNov 12, 2024
    Jun 30, 2024-$0.40-$0.41N/A+2.44%BeatN/AN/A0 up, 0 downAug 9, 2024
    Mar 31, 2024-$0.46-$0.39-$0.45 - -$0.33-17.95%MissN/A20 up, 0 downMay 14, 2024
    Dec 31, 2023-$0.40-$0.39-$0.43 - -$0.35-2.56%MissN/A20 up, 0 downMar 21, 2024
    Sep 30, 2023-$0.36-$0.38-$0.39 - -$0.38+5.26%BeatN/A20 up, 0 downNov 7, 2023
    Jun 30, 2023-$0.35-$0.43-$0.43 - -$0.33+18.60%BeatN/A20 up, 0 downAug 8, 2023
    Mar 31, 2023-$0.38-$0.42-$0.42 - -$0.38+9.52%BeatN/A20 up, 0 downMay 8, 2023
    Dec 31, 2022-$0.35-$0.41-$0.42 - -$0.41+14.63%BeatN/A20 up, 0 downMar 24, 2023
    Sep 30, 2022-$0.49-$0.49N/A0.00%In lineN/AN/AN/ANov 9, 2022
    Jun 30, 2022-$0.07N/AN/AN/AN/AN/AN/AN/AAug 8, 2022
    Sep 30, 2021-$1.02N/AN/AN/AN/AN/AN/AN/ADec 22, 2021
    Last 19 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.75, after -$1.29 the year before. It was -$1.93 for the year ended Dec 31, 2022, the oldest of the 4 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.75N/A
    Dec 31, 2024-$1.29N/A
    Dec 31, 2023-$1.49N/A
    Dec 31, 2022-$1.93N/A

    Frequently Asked Questions About MAIA

    When is MAIA Biotechnology's next earnings date?

    MAIA Biotechnology's next earnings report is expected for Mar 22, 2027.

    Did MAIA beat earnings estimates last quarter?

    Yes. MAIA Biotechnology reported EPS of -$0.12 for the quarter ended Sep 30, 2026, above the -$0.13 estimate, a 7.69% surprise.

    What EPS do analysts expect from MAIA next quarter?

    The consensus EPS estimate for MAIA Biotechnology for the quarter ending Dec 31, 2026 is -$0.14 from 3 analysts.

    How often does MAIA beat earnings estimates?

    MAIA Biotechnology beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +1.51%.